NCT02832362

Local Nasal Tolerability and Safety Study of 1146A in Healthy Adult Participants

A Randomized, Parallel-Group, Placebo-Controlled Study to Evaluate the Local Nasal Tolerability and Safety of 1146A in Healthy Adult Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 30 (actual)
• Sponsor: GlaxoSmithKline · Industry
• Sex: All
• Age: 18 Years – 55 Years
• Healthy volunteers: Accepted

Summary

This will be a single-center, randomized, parallel-group, placebo-controlled study to assess the local nasal tolerability and safety of multiple administrations of topically (intranasally) administered 1146A delivered by a nasal spray applicator in healthy adult participants

Conditions

• Common Cold

Interventions

Type	Name	Description
DRUG	Carbomer 980	Test product containing 0.5% carbomer 980 gel
OTHER	Placebo	Reference product containing vehicle without 0.5% carbomer 980 gel

Timeline

• Start date: 2016-06-11
• Primary completion: 2016-07-10
• Completion: 2016-07-18
• First posted: 2016-07-14
• Last updated: 2017-06-29

Locations

1 site across 1 country: Canada